Reproductive Health Flashcards
generic name and class
premarin
generic: conjugated estrogens
class:estrogens
indication
premarin
Abnormal uterine bleeding (acute); breast cancer (metastatic, palliative); postmenopausal osteoporosis prevention, prostate cancer (palliative); secondary amenorrhea due to hypoestrogenism, vasomotor symptoms associated with menopause with or without vulvar/vaginal atrophy associated with menopause
MOA
premarin
he mixture of estrogens in this product replace the estrogens produced by the body responsible for the development and maintenance of the fame reproductive system and secondary sex characteristics. Responsible for modulation of gonadotropins (luteinizing hormone and follicle stimulating hormone) through negative feedback
major contraindications
premarin
Angioedema or anaphylactic reaction to estrogens or any component of the formulation; undiagnosed
abnormal genital bleeding; DVT or PE (current or history of); active or history of arterial thromboembolic disease (eg, stroke, MI); breast cancer (except in appropriately selected patients
being treated for metastatic disease); estrogen-dependent tumor (known or suspected); hepatic impairment or disease; known protein C, protein S, antithrombin deficiency or other known
thrombophilic disorders; pregnancy
BBW
premarin
Endometrial cancer, breast cancer, cardiovascular disease, dementia, risk v. benefit
common ADRs
premarin
> more than 10%: Weight change, headache, migraine, depression, disorder of menstruation, breast pain
1-10%: Edema, vasodilation, abdominal pain, hirsutism, diarrhea, nausea, stomach cramps, vomiting, backache
rare but serious ADRs
premarin
Heart disease, HTN, MI, breast cancer, diabetes mellitus, hypercalcemia, venous thromboembolism,
anaphylaxis, cerebrovascular accident, cervical cancer, malignant neoplasm of endometrium of corpus uteri, ovarian cancer, PE
key counseling points
premarin
Discuss potential long-term adverse effects of hormone therapy including MI, stroke, DVT, PE, and breast cancer. Take at bedtime to minimize side effects. Take with or without meals
generic name and class
estrace
generic: estradiol
class: estrogens (oral)
indication
estrace
Abnormal uterine bleeding (acute); breast cancer (metastatic, palliative); postmenopausal osteoporosis prevention, prostate cancer (palliative); secondary amenorrhea due to hypoestrogenism, vasomotor symptoms associated with menopause with or without vulvar/vaginal atrophy associated with menopause
MOA
estrace
Estradiol (a form of estrogen) in this product replaces the estrogens produced by the body responsible for the development and maintenance of the fame reproductive system and secondary sex characteristics. Responsible for modulation of gonadotropins (luteinizing hormone and follicle stimulating hormone) through negative feedback
major contraindications
estrace
Angioedema or anaphylactic reaction to estrogens or any component of the formulation; undiagnosed abnormal genital bleeding; DVT or PE (current or history of); active or history of arterial
thromboembolic disease (eg, stroke, MI); breast cancer (except in appropriately selected patients being treated for metastatic disease); estrogen-dependent tumor (known or suspected); hepatic impairment or disease; known protein C, protein S, antithrombin deficiency or other known
thrombophilic disorders; pregnancy
BBW
estrace
Endometrial cancer, breast cancer, cardiovascular disease, dementia, risk v. benefit
common ADRs
estrace
1-10%: Weight change, nausea, vomiting, disturbance in mood, swelling of breast, depression
rare but serious ADRs
estrace
Heart disease, MI, DM, venous thromboembolism, anaphylaxis, cerebrovascular accident, PE, breast,
endometrial or ovarian cancer
key counseling points
estrace
Report abnormal vaginal bleeding or signs/symptoms of a thromboembolic disorder. Do not smoke during therapy, as this increases the risk of thromboembolic events.
generic name and class
alora, climara, minivelle, menostar, vivelle-DOT, estraderm
generic: estradiol transdermal patch
class: estrogens
generic name and class
prometrium
generic: progesterone
class: progestins
oral, vaginal gel or insert
indication
prometrium
Prevention of estrogen-induced endometrial hyperplasia (oral) )while conjugated estrogens are administered; secondary physiologic amenorrhea (oral or gel); assisted reproduction for infertile women (gel or insert)
MOA
prometrium
Progesterone transforms proliferative endometrium into secretory endometrium. Systemically administered progesterone inhibits gonadotropin production, which in turn prevents follicular maturation and ovulation
major contraindications
prometrium
Abnormal vaginal bleeding, history of estrogen- or progesterone-dependent neoplasia, active or history of DVT or PE, known or suspected pregnancy
BBW
prometrium
Should not be used for the prevention of cardiovascular disorders, dementia or breast cancer
common ADRs
prometrium
> 10%: weight changes, headache, amenorrhea, breast tenderness, abdominal pain
1-10%: nausea, asthenia, feeling nervous, break through bleeding
rare but serious ADRs
prometrium
Thromboembolism (DVT, PE), thrombophlebitis, osteoporosis
key counseling points
prometrium
If using for amenorrhea, menstrual bleeding should occur 3-7 d after last oral dose. Report if menstruation does not occur within 7 d after last dose. For vaginal formulation, avoid using other
vaginal drugs within 6 h before or 6 h after using progesterone
generic name and class
provera - oral, depo-provera - injection
generic: medroxyprogesterone
class: progestins
indication
medroxyprogesterone
Abnormal uterine bleeding unrelated to menstrual cycle (oral); prevention of estrogen-induced endometrial hyperplasia (oral); secondary physiologic amenorrhea (oral); prevention of pregnancy (injection); endometriosis (injection)
MOA
medroxyprogesterone
Medroxyprogesterone transforms proliferative into secretory endometrium. Androgenic and
anabolic effects have been noted, but the drug is devoid of significant estrogenic activity.